9-hydroxy-10,12-octadecadienoic acid has been researched along with gw9662 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bentel, JM; Brownrigg, LM; Croft, KD; Dharmarajan, AM; Hampel, JK; Puddey, IB; Vignarajah, D; Yeap, BB | 1 |
1 other study(ies) available for 9-hydroxy-10,12-octadecadienoic acid and gw9662
Article | Year |
---|---|
Differential modulation of cell cycle, apoptosis and PPARgamma2 gene expression by PPARgamma agonists ciglitazone and 9-hydroxyoctadecadienoic acid in monocytic cells.
Topics: Anilides; Animals; Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Cycle Proteins; Cell Differentiation; Cell Line; Cell Survival; Gene Expression; Humans; Hypoglycemic Agents; Linoleic Acids; Linoleic Acids, Conjugated; Monocytes; PPAR gamma; Thiazolidinediones; Transcription Factors; U937 Cells | 2006 |